Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling-Reference-Cited by-同舟云学术

Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling

Published:2018-01 Issue:1 Volume:73 Page:71-78
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Pal Sumanta K.,Ali Siraj M.,Yakirevich Evgeny,Geynisman Daniel M.,Karam Jose A.,Elvin Julia A.,Frampton Garrett M.,Huang Xuan,Lin Douglas I.,Rosenzweig Mark,Lipson Doron,Stephens Philip J.,Ross Jeffrey S.,Miller Vincent A.,Agarwal Neeraj,Shuch Brian,Choueiri Toni K.,Chung Jon H.

Publisher

Elsevier BV

Subject

Urology

Reference42 articles.

1. Comprehensive molecular characterization of papillary renal-cell carcinoma;The Cancer Genome Atlas Network;N Engl J Med,2015

2. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era;Pal;PloS One,2013

3. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

4. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma;Journal of Clinical Oncology;2024-09-10

2. Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances;American Society of Clinical Oncology Educational Book;2024-06

3. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel;Cancers;2024-05-25

4. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data;Urologic Oncology: Seminars and Original Investigations;2024-05

5. The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy;Pharmaceuticals;2024-03-30